Private wealth manager Bernstein has previously predicted that the obesity market in the US could be worth up to DKK 500bn (USD 72bn) within ten years – and Zealand Pharma wants in.
”If you look around, a lot of the large companies are realizing that they should get into obesity treatments, but they don’t have a pipeline. In that respect, Zealand Pharma is a relatively interesting player to team up with for access,” CEO Adam Steensberg tells Danish financial daily Børsen.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Covid vaccine race lights fire under GSK boss as RSV battle intensifies
GSK Plc is planning to launch a Covid shot that comes almost two years after Pfizer Inc. took the world by storm. For Phil Dormitzer, it’s a reminder of why he was hired at the UK drugmaker: to help return its immunization business to the top after it stumbled during the pandemic.
Bavarian Nordic to supply US with additional 2.5 million monkeypox vaccines
The deliveries will start in the fourth quarter of 2022 and continue into 2023, when the majority of the doses will be provided.
Genmab to submit cancer candidate epcoritamab to the FDA before year-end
The US Food and Drug Administration will receive a marketing authorization application from Genmab and partner Abbvie in the second half of this year.
Novo Nordisk denied general conditional reimbursement for Wegovy in Denmark – again
The Danish Medicines Agency has been told for the second time that the price of the obesity drug is not in line with the effect it provides.
Bavarian Nordic is working with EMA on monkeypox vaccine label expansion
Bavarian Nordic’s smallpox vaccine Imvanex has previously been used off-label to protect close contacts from monkeypox in several countries. The Danish vaccine firm is now working with the EMA to expand the label in an ”accelerated process.”
Experienced Device Developer 
Global Product Manager - ENT 
Corporate Quality Compliance Specialist for Audit Management 
Chair of the Board 
Senior Electronics Engineer 
Regulatory Affairs Manager - Maternity Cover 
Open position for a Clinical Trial Manager to join our team at Nykode! 
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
KLIFO is looking for a Clinical Trial Assistant for our office in Glostrup, Lund or Münich 
Director Regulatory Affairs 
Senior Manager/Associate Director, Global Regulatory Affairs, CMC 
Nordic Medical Advisor 
Project Managers keep all of us healthy 
Antibody Engineering Scientist